← FDA DRUG APPROVALS
FDA ANDA · ANDA078492
FLUTICASONE PROPIONATE SPRAY, METERED
fluticasone propionate
Sponsor: CHARTWELL RX
APPLICATION
ANDA078492
TYPE
ANDA
ORIGINAL APPROVAL
2012-01-09
LATEST ACTION
2025-07-18
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription
Products
FLUTICASONE PROPIONATEPrescription
FLUTICASONE PROPIONATE 0.05MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2025-07-18Labeling · Supplement 13 · standardAP
2016-03-14Labeling · Supplement 5 · standardAP
2012-01-09OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.